Terms: = Breast cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
337 results:
1. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
[No Abstract] [Full Text] [Related]
3. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY
Breast Cancer Res; 2023 Dec; 25(1):149. PubMed ID: 38066611
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time - An Australian population-based record linkage study, 2001-2016.
Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N
Eur J Cancer; 2024 Jan; 197():113468. PubMed ID: 38061215
[TBL] [Abstract] [Full Text] [Related]
5. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
6. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
[TBL] [Abstract] [Full Text] [Related]
8. Postmastectomy radiotherapy in patients with T
Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
[TBL] [Abstract] [Full Text] [Related]
9. Meta-analysis of Osteopontin splice variants in cancer.
An Y; Fnu G; Xie C; Weber GF
BMC Cancer; 2023 Apr; 23(1):373. PubMed ID: 37095438
[TBL] [Abstract] [Full Text] [Related]
10. Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Garcia-Tejedor A; Falo C; Fernandez-Gonzalez S; Laplana M; Gil-Gil M; Soler-Monso T; Martinez-Perez E; Calvo I; Calpelo H; Bajen MT; Benitez A; Ortega R; Petit A; Guma A; Campos M; Stradella A; Lopez-Ojeda A; Ponce J; Pla MJ; Pernas S
Breast Cancer Res Treat; 2023 Jun; 199(3):445-456. PubMed ID: 37043108
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
12. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.
Gampenrieder SP; Dezentjé V; Lambertini M; de Nonneville A; Marhold M; Le Du F; Cortés Salgado A; Alpuim Costa D; Vaz Batista M; Chic Ruché N; Tinchon C; Petzer A; Blondeaux E; Del Mastro L; Targato G; Bertucci F; Gonçalves A; Viret F; Bartsch R; Mannsbart C; Deleuze A; Robert L; Saavedra Serrano C; Gion Cortés M; Sampaio-Alves M; Vitorino M; Pecen L; Singer C; Harbeck N; Rinnerthaler G; Greil R;
ESMO Open; 2023 Feb; 8(1):100747. PubMed ID: 36563519
[TBL] [Abstract] [Full Text] [Related]
13. The Complex Management of the breast Angiosarcoma: A Retrospective Study.
Cannella L; Perri F; Clemente O; von Arx C; Pizzolorusso A; Di Bonito M; Bracigliano A; Di Marzo M; Della Vittoria Scarpati G; De Chiara A; Tafuto S
Oncology; 2023; 101(4):234-239. PubMed ID: 36538913
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer.
Viansone A; Pellegrino B; Omarini C; Pistelli M; Boggiani D; Sikokis A; Uliana V; Zanoni D; Tommasi C; Bortesi B; Bonatti F; Piacentini F; Cortesi L; Camisa R; Sgargi P; Michiara M; Musolino A
Breast; 2022 Oct; 65():145-150. PubMed ID: 35970028
[TBL] [Abstract] [Full Text] [Related]
16. Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool.
Leone JP; Graham N; Tolaney SM; Leone BA; Freedman RA; Hassett MJ; Leone J; Vallejo CT; Winer EP; Lin NU; Tayob N
Eur J Cancer; 2022 Sep; 173():20-29. PubMed ID: 35841843
[TBL] [Abstract] [Full Text] [Related]
17. Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
Chen H; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Poon I; Redmond KJ; Ricardi U; Sahgal A; Louie AV
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):902-909. PubMed ID: 35753554
[TBL] [Abstract] [Full Text] [Related]
18. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
19. Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse breast cancer prognosis.
Zeng E; He W; Smedby KE; Czene K
J Natl Compr Canc Netw; 2022 Apr; 20(6):683-689.e2. PubMed ID: 35385829
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean breast cancer Society.
Won HS; Ahn J; Kim Y; Kim JS; Song JY; Kim HK; Lee J; Park HK; Kim YS
Breast Cancer Res; 2022 Mar; 24(1):22. PubMed ID: 35307014
[TBL] [Abstract] [Full Text] [Related]
[Next]
